Company Analysis

Entera Bio Ltd. (ENTX)

Nasdaq: ENTX · Biological Products, (No Diagnostic Substances) · Jerusalem · filing with the SEC since 2015
Grade3.9
◀ Past 3.4● Present 3.5▶ Future 4.5
1 est.

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

8 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Entera Bio Ltd.’s names, not what it holds today.

Patents granted
8
8 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 1 in 2024 and none in 2023
Applications published
19
5 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'15'16'18'19'20'22'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals4
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Entera Bio Ltd. its own name
IL, as the owner printed on each patent
8 granted
16 published
Entera Bio Ltd. its own name
named as the applicant on its applications, in IL
0 granted
3 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
May 27, 202512,311,051Methods and compositions for oral administrationPharmaceuticalsEntera Bio Ltd.
Mar 4, 202512,239,691Formulations for oral administration of active agentsPharmaceuticalsEntera Bio Ltd.
Sep 3, 202412,076,373Formulations for oral administration of active agentsPharmaceuticalsEntera Bio Ltd.
Feb 15, 202211,246,827Methods and compositions for oral administrationPharmaceuticalsEntera Bio Ltd.
Mar 10, 202010,583,177Formulations for oral administration of active agentsPharmaceuticalsEntera Bio Ltd.
Sep 24, 201910,420,721Methods and compositions for oral administrationPharmaceuticalsEntera Bio Ltd.
Jul 3, 201810,010,503Methods and compositions for oral administrationPharmaceuticalsEntera Bio Ltd.
Nov 17, 20159,186,412Methods and compositions for oral administration of insulinPharmaceuticalsEntera Bio Ltd.
Newest applications publishedan application is a clue, never a plan
What it applied for, 2024 to 2025: Pharmaceuticals 8.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton ENTX · research, not advice